SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-17
👔
HERON THERAPEUTICS, INC. /DE/
@HRTX_InsiderForm 4 Filing: Duarte Ira Surrenders for Taxes $1,350.9 of $HRTX
TAX WITHHOLDING
⚡ MATERIALITY: 2/10
corporate issuer
HERON THERAPEUTICS, INC. /DE/
Ticker: $HRTX
Transaction Value
$1,350.9
Price/Share: $0.08
transaction date
2026-06-16
Shares: 16,055
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Duarte Ira, holds the title of EVP, Chief Financial Officer at HERON THERAPEUTICS, INC. /DE/.
On 2026-06-16, the insider transacted 16,055 shares.The shares were transacted at a weighted average price of $0.08 per share, resulting in a total market-relevant value of $1,350.9.
Executive Summary Summary
Duarte Ira (EVP, Chief Financial Officer) had withheld for taxes $1K of $HRTX
Post-Transaction Position: 261,073 shares
SEC Accession No: 0001193125-26-273552 (CIK: 1488864)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.